Trivarx Ltd (AU:TRI) — Market Cap & Net Worth
Market Cap & Net Worth: Trivarx Ltd (TRI)
Trivarx Ltd (AU:TRI) has a market capitalization of $9.80 Million (AU$13.84 Million) as of September 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27212 globally and #1309 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trivarx Ltd's stock price AU$0.01 by its total outstanding shares 1153693464 (1.15 Billion). Also see TRI current and non-current assets for a full breakdown of the balance sheet.
Trivarx Ltd Market Cap History: 2015 to 2026
Trivarx Ltd's market capitalization history from 2015 to 2026. Data shows change from $4.45 Billion to $9.80 Million (-44.37% CAGR). Also see Trivarx Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Trivarx Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trivarx Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Trivarx Ltd for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
13.74x
Trivarx Ltd's market cap is 13.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $5.11 Billion | $23.10K | -$9.79 Million | 221418.34x | N/A |
| 2018 | $333.06 Million | $204.88K | -$16.30 Million | 1625.63x | N/A |
| 2019 | $158.61 Million | $364.63K | -$6.59 Million | 434.99x | N/A |
| 2020 | $130.61 Million | $133.50K | -$4.70 Million | 978.35x | N/A |
| 2021 | $89.79 Million | $101.66K | -$1.49 Million | 883.32x | N/A |
| 2022 | $32.65 Million | $40.04K | -$12.72 Million | 815.54x | N/A |
| 2023 | $24.49 Million | $22.07K | -$3.12 Million | 1109.42x | N/A |
| 2024 | $13.06 Million | $893.31K | -$1.24 Million | 14.62x | N/A |
| 2025 | $15.51 Million | $1.13 Million | -$943.23K | 13.74x | N/A |
Competitor Companies of TRI by Market Capitalization
Companies near Trivarx Ltd in the global market cap rankings as of September 19, 2026. Review TRI intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Trivarx Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #737 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1877 globally with a market cap of $12.53 Billion USD ( AU$17.71 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2153 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #737 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $260.21 |
| #1877 | Pro Medicus Ltd | AU:PME | $12.53 Billion | AU$169.57 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $77.84 |
| #2153 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $56.78 |
Trivarx Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Trivarx Ltd's market cap moved from $4.45 Billion to $ 9.80 Million, with a yearly change of -44.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$9.80 Million | -36.84% |
| 2025 | AU$15.51 Million | +18.75% |
| 2024 | AU$13.06 Million | -46.67% |
| 2023 | AU$24.49 Million | -25.00% |
| 2022 | AU$32.65 Million | -63.64% |
| 2021 | AU$89.79 Million | -31.25% |
| 2020 | AU$130.61 Million | -17.65% |
| 2019 | AU$158.61 Million | -52.38% |
| 2018 | AU$333.06 Million | -93.49% |
| 2017 | AU$5.11 Billion | -10.39% |
| 2016 | AU$5.71 Billion | +28.33% |
| 2015 | AU$4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Trivarx Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.80 Million USD |
| MoneyControl | $9.80 Million USD |
| MarketWatch | $9.80 Million USD |
| marketcap.company | $9.80 Million USD |
| Reuters | $9.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more